Investigation of exon skipping therapy in kidney organoids from Alport syndrome patients derived iPSCs
Genes to Cells · 2024
DOI: 10.1111/gtc.13170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Kensuke Yabuuchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Human Organogenesis, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Induced Pluripotent Stem Cells, Organoids, Exons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Alport syndrome (AS) is a hereditary disease caused by mutations in the COL4A5 gene and leads to chronic kidney disease. Currently, no specific treatment has been developed. However, a recent study using AS‐model mice demonstrated that the exon skipping method could partially rescue the symptoms. In this study, we evaluated the effects of the exon skipping method using kidney organoids generated from AS‐patient‐derived induced pluripotent stem cells (AS‐iPSCs). We generated kidney organoids from AS‐iPSCs, which exhibited nephron structures. As expected, the C‐terminus of COL4A5 was not expressed in AS‐organoids. Interestingly, anti‐sense oligonucleotides restored the expression of the C‐terminus of COL4A5 in vitro. Next, we transplanted AS‐organoids into mice and evaluated glomerular basement membrane formation in vivo. We found that AS‐organoids formed a lower slit diaphragm ratio compared to control organoids. Finally, we assessed the effects of exon skipping on transplanted organoids but observed minimum effects. These studies suggest that AS‐iPSCs can generate kidney organoids lacking the C‐terminus of COL4A5, and that exon skipping can induce its expression in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Human Organogenesis, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan.
- Department of Development and Regeneration, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
ORCID-Profile: Minoru Takasato
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Yabuuchi, K., Horinouchi, T., Yamamura, T., Nozu, K., & Takasato, M. (2024). Investigation of exon skipping therapy in kidney organoids from Alport syndrome patients derived iPSCs. Genes to Cells. https://doi.org/10.1111/gtc.13170
Vancouver
Yabuuchi K, Horinouchi T, Yamamura T, Nozu K, Takasato M. Investigation of exon skipping therapy in kidney organoids from Alport syndrome patients derived iPSCs. Genes to Cells. 2024. doi:10.1111/gtc.13170
BibTeX
@article{Yabuuchi2024,
author = {Yabuuchi, Kensuke and Horinouchi, Tomoko and Yamamura, Tomohiko and Nozu, Kandai and Takasato, Minoru},
title = {Investigation of exon skipping therapy in kidney organoids from Alport syndrome patients derived iPSCs},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13170}
}
EUVIMED